If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
458.00    3.00 (0.66%)
Bid:
451.00
Ask:
458.00
Spread: 7.00 (1.552%)
Market Cap: £226.13m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

Trading Update

18 Jul 2016 07:00

RNS Number : 3911E
City of London Investment Group PLC
18 July 2016
 

 

City of London Investment Group PLC

18 July 2016

 

This announcement contains inside information



CITY OF LONDON INVESTMENT GROUP PLC

("City of London" or "the Group")

 

TRADING UPDATE

for the year to 30 June 2016

 

City of London (LSE: CLIG), a leading emerging markets asset management group, provides a trading update for its financial year ended 30 June 2016. The numbers that follow are all unaudited.

 

Funds under management were US$4.0 billion (£3.0 billion) at 30 June 2016 (2015: US$4.2 billion or £2.7 billion), representing a 5% decrease in US$ terms and an 11% increase in GBP terms as a result of the exchange rate moving from 1.57 to 1.33 over the period. Over the same period, the MSCI Emerging Markets TR Net Index fell by 12% in US$ terms, resulting in a relative change in funds under management of +7% versus the benchmark, a product of both positive investment performance and new and existing client inflows.

 

Investment performance in the emerging markets closed-end fund (CEF) strategy continues to be strong, with results in the first or second quartile versus manager peers for the year ending 30 June 2016. The current size-weighted average discount (SWAD) across client portfolios is c. 14%-15%, indicating that there is still present significant relative value in the strategy. The investment approach adds value beyond this by exploiting volatility of the underlying discounts in the CEF universe, from which portfolios are constructed with their specific SWAD characteristics plus active country allocation.

 

The Group's overheads for the year to 30 June 2016 are expected to be £10.7 million (2015: £9.4 million) and the current monthly run-rate is c£0.9m.

 

For the year to 30 June 2016, City of London expects that pre-tax profits will be approximately £8.0 million (2015: £8.9 million), and that profits after an anticipated tax charge of £2.0 million (25% of pre-tax profits) will be approximately £5.9 million (2015: profits of £6.6 million after a tax charge of £2.3 million, representing 26% of pre-tax profit). Basic and fully diluted earnings per share are expected to be 23.6p and 23.5p respectively (2015: 26.4p and 26.0p).

 

As a result of the fall in Emerging Markets during the financial year, earnings cover will be reduced this year but given the Group's strong cash position and optimism with regard to the future, the Board is recommending a maintained final dividend of 16p per share (2015: 16p). This would bring the total for the year to 24p (2015: 24p), a dividend cover of 0.98 times earnings per share (2015: 1.1 times).

 

The Board confirms the final dividend timetable for the year to 30 June 2016:

 

· ex-dividend date: 13 October 2016

· dividend record date: 14 October 2016

· payable: 31 October 2016

 

 

City of London expects to announce final results alongside publication of its Accounts for the year to 30 June 2016 on 12 September 2016. The Group's Annual General Meeting will be held on 17 October 2016.

 

Business Update

 

· Virtually all CLIM income is USD based - our fees are sourced from US Institutions

· Zero FUM effect from BREXIT - zero redemptions FYTD

· Over 90% of CLIM income on a see through basis is effectively derived from the Emerging Markets

· Approximately 40% of Group costs are in GBP

· Only 2.5% of CLIM assets are UCIT'S - very little fall out from BREXIT

 

Template

 

Please see the attached graph which is based on the following assumptions and includes the estimated cost of a maintained dividend:

 

http://www.rns-pdf.londonstockexchange.com/rns/3911E_1-2016-7-17.pdf

 

Assumptions:

- Starting point Current FuM (end June 2016)

- Net increase in FuM in 2016/2017 (straight-lined to June 2017):

· emerging market strategies $250m

· diversification strategies $250m

- Operating margin adjusted monthly for change in product mix and commission run-off

- Market growth: 0%

- Increase in overhead: 5%

- Corporation tax based on an estimated average rate of 26%

- Exchange rate assumed to be £1/$1.35 for entire period

- Number of CLIG Shares in issue (26.9m) less those held by the ESOP Trust (1.9m) as at 30 June 2016

 

This can also be found on our website at: http://www.citlon.co.uk/shareholders/announcements.php

 

 

For further information, please visit http://www.citlon.co.uk/ or contact:

 

Barry Olliff, CEO

City of London Investment Group PLC

Tel: 001 215 313 3774

 

Martin R Green

Zeus Capital Limited

Financial Adviser & Broker

Tel: +44 (0)20 3829 5000

 

This release includes forward-looking statements, which may differ from actual results. Any forward-looking statements are based on certain factors and assumptions, which may prove incorrect, and are subject to risks, uncertainties and assumptions relating to future events, the Group's operations, results of operations, growth strategy and liquidity.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFSFAWFMSEIW
Date   Source Headline
10th Oct 20175:27 pmRNSHolding(s) in Company
10th Oct 201712:20 pmRNSDirector/PDMR Shareholding
9th Oct 20177:00 amRNSAGM Trading Update
3rd Oct 20174:12 pmRNSHolding(s) in Company
28th Sep 20174:30 pmRNSHolding(s) in Company
22nd Sep 201711:08 amRNSHolding(s) in Company
18th Sep 20177:00 amRNSFinal Results
8th Sep 20177:53 amRNSDirector/PDMR Shareholding
31st Aug 20174:00 pmRNSOpen letter to the board of icapital.biz Berhad
20th Jul 20176:22 pmRNSHolding(s) in Company
19th Jul 20177:00 amRNSTrading Update
13th Jul 20176:15 pmRNSHolding(s) in Company
13th Jul 20177:00 amRNSChange of announcement date
13th Jun 20174:26 pmRNSBoard Changes
26th May 20173:49 pmRNSDirector/PDMR Shareholding
25th May 20172:12 pmRNSDirector/PDMR Shareholding
22nd May 201712:56 pmRNSHolding(s) in Company
8th May 20176:03 pmRNSShare Buyback and Total Voting Rights
26th Apr 20173:37 pmRNSHolding(s) in Company
18th Apr 20171:56 pmRNSDirector/PDMR Shareholding
11th Apr 20177:00 amRNSTrading Update
3rd Apr 201712:42 pmRNSHolding(s) in Company
24th Mar 20172:28 pmRNSHolding(s) in Company
21st Mar 20175:20 pmRNSHolding(s) in Company
22nd Feb 20171:40 pmRNSDirector/PDMR Shareholding
22nd Feb 20171:37 pmRNSDirector/PDMR Shareholding
20th Feb 20177:46 amRNSHALF YEAR RESULTS TO 31ST DECEMBER 2016
24th Jan 20173:24 pmRNSHardman Research:Q2 statement robust profitability
17th Jan 20177:00 amRNSFunds Under Management - Trading Update
24th Nov 20163:42 pmRNSDirector/PDMR Shareholding
19th Oct 201611:15 amRNSAGM resolutions
17th Oct 20165:49 pmRNSResult of AGM
13th Oct 20163:05 pmRNSDirector/PDMR Shareholding
11th Oct 20165:13 pmRNSHolding(s) in Company
11th Oct 20162:51 pmRNSDirector/PDMR Shareholding
10th Oct 20167:46 amRNSAGM Trading Update - 1st Qtr Funds under Mgmt
15th Sep 20169:46 amRNSLetter to icapital.biz Berhad
14th Sep 20169:32 amRNSHardman Report: Exchange rate moves give big boost
12th Sep 20167:00 amRNSFINAL RESULTS FOR THE YEAR TO 30TH JUNE 2016
18th Jul 20167:00 amRNSTrading Update
1st Jul 20167:00 amRNSBlock listing cancellation & block listing return
30th Jun 20164:40 pmRNSSecond Price Monitoring Extn
30th Jun 20164:35 pmRNSPrice Monitoring Extension
23rd Jun 20165:55 pmRNSDirector/PDMR Shareholding
14th Apr 201612:38 pmRNSHardman & Co Issues Research Report
22nd Feb 201611:18 amRNSDirector/PDMR Shareholding
15th Feb 20167:00 amRNSHalf Yearly Report
5th Feb 20164:40 pmRNSSecond Price Monitoring Extn
5th Feb 20164:35 pmRNSPrice Monitoring Extension
29th Jan 20164:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.